Increased selenium levels associated with reduced risk of colorectal cancer
the ONA take:
Increased levels of selenium, a mineral found in soil and some foods that is key to metabolism function, have been associated with a lower risk of colorectal cancer.
Research conducted by investigators based at Newcastle University, UK, the International Agency for research on Cancer (IARC-WHO), and the Royal College of Surgeons in Ireland, determined that Europeans average 80 micrograms of selenium, well below the 110-170 range seen in North America.
These lower selenium averages are probably due to a lower selenium soil content in Europe. (Current recommended dietary allowance [RDA] of selenium for adults is at least 55 micrograms per day, with a safe upper limit of 400 micrograms per day.)
The team examined selenium levels in the blood as well as selenoprotein O P levels, and they determined that a higher selenium level correlates to a lower colorectal cancer risk, with a greater correlation for women.
Although they acknowledge the need for additional study, they feel that a dietary supplement containing selenium could be beneficial for populations in which naturally occurring selenium levels are insufficient.
Increased levels of selenium have been associated with a lower risk of colorectal cancer.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|